Senior insider sale
KEROS THERAPEUTICS, INC. — senior position signals high conviction
$497.4K
45.06K shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 45.06K shares of KEROS THERAPEUTICS, INC. valued at approximately $497.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0000947871-26-000370
Director
Since Apr 2020
45.06K
Shares to sell
$497.4K
Approx. market value
45.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
IPO
Cash
4/13/2020
45.06KTotal acquired45.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2020 | IPO Cash | 45.06K | — |
| Total | 45.06K | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
45.06K
Market value
$497.4K
3/31/2026
Total
Units
45.06K
Value
$497.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/31/2026 | 45.06K | $497.4K | Nasdaq Stock Market | Planned |
| Total | 45.06K | $497.4K | ||